182 related articles for article (PubMed ID: 33423307)
1. First annual report of Chinese haemovigilance network.
Yin Y; Tian X; Li L; Kong Y; Wang J; Lin F; Song N; Chen Q; Gan J; Peng T; Li X; Wu Y; Ge H; Wang H; Jiang J; Bai L; Ji H; Zhao G; Huang Y; Liu Z;
Vox Sang; 2021 Jul; 116(6):718-724. PubMed ID: 33423307
[TBL] [Abstract][Full Text] [Related]
2. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016.
Politis C; Wiersum-Osselton J; Richardson C; Grouzi E; Sandid I; Marano G; Goto N; Condeço J; Boudjedir K; Asariotou M; Politi L; Land K
Transfus Clin Biol; 2022 Aug; 29(3):243-249. PubMed ID: 35476961
[TBL] [Abstract][Full Text] [Related]
4. Acute blood transfusion reactions in a tertiary care hospital in Pakistan - an initiative towards haemovigilance.
Borhany M; Anwar N; Tariq H; Fatima N; Arshad A; Naseer I; Shamsi T
Transfus Med; 2019 Aug; 29(4):275-278. PubMed ID: 29845667
[TBL] [Abstract][Full Text] [Related]
5. International haemovigilance: what have we learned and what do we need to do next?
Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
[TBL] [Abstract][Full Text] [Related]
6. Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020.
Tian X; Kong Y; Wang J; He R; Li L; Liu Z;
Vox Sang; 2022 Aug; 117(8):1027-1034. PubMed ID: 35560059
[TBL] [Abstract][Full Text] [Related]
7. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.
Wiersum-Osselton JC; Whitaker B; Grey S; Land K; Perez G; Rajbhandary S; Andrzejewski C; Bolton-Maggs P; Lucero H; Renaudier P; Robillard P; Santos M; Schipperus M
Lancet Haematol; 2019 Jul; 6(7):e350-e358. PubMed ID: 31080132
[TBL] [Abstract][Full Text] [Related]
8. Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.
Rogers MA; Rohde JM; Blumberg N
Vox Sang; 2016 Apr; 110(3):266-77. PubMed ID: 26689441
[TBL] [Abstract][Full Text] [Related]
9. Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances.
McVey MJ; Cohen R; Arsenault V; Escorcia A; Tasmin F; Pendergrast J; Lieberman L; Lin Y; Callum J; Cserti-Gazdewich C
Vox Sang; 2021 Sep; 116(8):898-909. PubMed ID: 33634884
[TBL] [Abstract][Full Text] [Related]
10. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.
Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR
Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576
[TBL] [Abstract][Full Text] [Related]
11. Haemovigilance: an effective tool for improving transfusion practice.
de Vries RR; Faber JC; Strengers PF;
Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010.
Piccin A; Cronin M; Brady R; Sweeney J; Marcheselli L; Lawlor E
Transfusion; 2015 Jun; 55(6):1223-30. PubMed ID: 25522667
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Adverse Transfusion Reactions in a Tertiary Care Centre of North India: A Step Towards Hemovigilance.
Bassi R; Aggarwal S; Bhardwaj K; Thakur KK
Indian J Hematol Blood Transfus; 2017 Jun; 33(2):248-253. PubMed ID: 28596659
[TBL] [Abstract][Full Text] [Related]
14. The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers.
Bosboom JJ; Klanderman RB; Peters AL; van de Weerdt EK; Goudswaard EJ; Binnekade JM; Zwaginga JJ; Beckers EAM; Geerts BF; Hollmann MW; Zeerleder SS; van Kraaij M; Vlaar AP
Transfus Med; 2018 Oct; 28(5):363-370. PubMed ID: 29058354
[TBL] [Abstract][Full Text] [Related]
15. Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project.
Townsend M; Maryuningsih Soedarmono YS; Narayan S; Ashford P; Wood EM; Whitaker BI
Vox Sang; 2024 Mar; 119(3):277-281. PubMed ID: 38126141
[TBL] [Abstract][Full Text] [Related]
16. Eight years with haemovigilance in Norway. What have we learnt?
Steinsvåg CT; Espinosa A; Flesland Ø
Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
[TBL] [Abstract][Full Text] [Related]
17. The impact of revised definitions for transfusion-associated circulatory overload and transfusion-related acute lung injury on haemovigilance reporting.
Yuan Y; Dennington PM; Daly J; Baidya S; Tung JP
Vox Sang; 2023 Mar; 118(3):199-206. PubMed ID: 36654528
[TBL] [Abstract][Full Text] [Related]
18. Conference report: International Haemovigilance Seminar and the SHOT Annual Symposium, 10-12 July 2018.
Bolton-Maggs PHB
Transfus Med; 2019 Aug; 29(4):247-252. PubMed ID: 30592099
[TBL] [Abstract][Full Text] [Related]
19. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021).
Lemssahli I; Benajiba M; Belmekki A
Pan Afr Med J; 2024; 47():60. PubMed ID: 38646139
[TBL] [Abstract][Full Text] [Related]
20. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
Moncharmont P; Quittançon E; Barday G; Benamara A;
Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
